Novavax
Clinical trials sponsored by Novavax, explained in plain language.
A vaccine company known for its COVID-19 vaccine and other infectious disease vaccines.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New novavax JN.1 vaccine trial aims to protect adults 50-64 from COVID Results expected Nov 2026 (estimated)
-
One shot for two threats: new combo vaccine tested in seniors
Vaccine CompletedThis large, final-stage study tested a new combination vaccine that aims to protect against both COVID-19 and the flu with a single shot. About 9,300 adults aged 65 and older took part, receiving either the combo vaccine or a standard high-dose flu vaccine. Researchers checked ho…
Phase 3 • Sponsor: Novavax • Aim: Vaccine
Last updated Jun 27, 2026 13:03 UTC
-
Novavax vaccine trial for kids under 12 shows promise
Vaccine CompletedThis study tested Novavax's COVID-19 vaccine in 3,600 children aged 6 months to 12 years. The goal was to see if the vaccine is safe and triggers a strong immune response. Children received two doses 21 days apart, with some getting a placebo. The trial is complete, and results w…
Phase 2/3 • Sponsor: Novavax • Aim: Vaccine
Last updated Jun 27, 2026 12:37 UTC
-
Novavax confirms its COVID-19 vaccine works the same across different batches
Vaccine CompletedThis study tested whether three different manufacturing batches (lots) of Novavax's COVID-19 vaccine produce the same immune response and safety in adults. About 900 healthy adults aged 18 to 49 who had already been vaccinated received one of the three lots. The results help ensu…
Phase 3 • Sponsor: Novavax • Aim: Vaccine
Last updated Jun 27, 2026 12:09 UTC
-
Which COVID-19 shot causes fewer side effects? new study compares novavax and pfizer
Knowledge-focused CompletedThis completed study looked at how often healthcare workers and first responders experienced short-term side effects (like fever or sore arm) after getting either the updated Novavax or Pfizer COVID-19 vaccine. About 660 adults who had at least one prior COVID-19 shot took part. …
Phase 4 • Sponsor: Novavax • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC